Why do some people get severe COVID-19? The nose may know
The body’s first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new…
The body’s first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new…
Cardiovascular drugs do not affect COVID-19 outcomes–such as disease severity, hospitalizations, or deaths–according to an analysis of all relevant studies…
New research has shown that early testing for blood clots in patients who had received the AstraZeneca/Oxford vaccine led to…
Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to coronavirus infection may be the cause of previously unexplained long…
Vivid photos of the red “COVID arm” rash and reports of facial swelling in patients who have received dermatological fillers…
A review of more than 9,000 U.S. patients with severe COVID-19 infection showed less than 1% contracted the illness again,…
While previous research early in the pandemic suggested that vitamin D cuts the risk of contracting COVID-19, a new study…
A multidisciplinary team from MassGeneral Hospital for Children (MGHfC), Brigham and Women’s Hospital and other institutions have identified the mechanism…
An international team of scientists from the Menzies Health Institute Queensland (MHIQ) at Griffith University and from City of Hope,…
Writing in the New England Journal of Medicine, a trio of science communication researchers proposes to treat the Covid-19 misinformation…
A comprehensive review into what we know about COVID-19 and the way it functions suggests the virus has a unique…
Many people in Switzerland experienced considerable psychological distress during the first COVID-19 lockdown from mid-March to the end of April…
As researchers continue to study the neurological impacts of COVID-19, a Houston Methodist international collaboration has documented an unexpectedly frequent…
Can a high dose of vitamin D administered on admission to hospital improve the condition of patients with moderate or…
The largest study of its type in the UK has identified differences in the immune response to COVID-19, between people…
People who trust television and Facebook to provide them with accurate news about the coronavirus pandemic are less knowledgeable about…
The faster-spreading B.1.1.7 variant of SARS-CoV-2 first detected in the United Kingdom, the coronavirus that causes COVID-19, is quickly on…
Testing and vaccination – these are the pillars on which humanity is trying to get a grip on the Coronavirus…
People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection…
Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is…
George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality…
The fast-spreading UK, South Africa, and Brazil coronavirus variants are raising both concerns and questions about whether COVID-19 vaccines will…
In an analysis that explores the structural underpinnings of a SARS-CoV-2 strain, G614, that quickly became dominant early in the…
Inflammatory heart disease is a rare finding among professional athletes with mild or asymptomatic COVID-19 infection, a large-scale study has…
COVID-19 has altered the labor market for millions of people, including public health graduates, yet an analysis of job postings…
Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ability to pump blood and abnormal…
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for…
The COVID-19 pandemic has prompted considerable investigation into how the SARS-CoV-2 Spike protein attaches to a human cell during the…
A combination of robust vaccination programmes and strict physical distancing rules could avoid recurring peaks of COVID-19 without the need…
Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability and intensity can vary by individual, prompting…